Mutations in the breast cancer susceptibility gene BRCA2 leading to the failure of interactions with the recombinase RAD51 are associated with an increased risk of cancer in humans. This interaction depends on the eight BRC repeat (BRC1-8) sequences in BRCA2. We previously reported that canine BRC3 has two polymorphisms (T1425P and K1435R) influencing the interaction with RAD51, and 1435R was identified in mammary tumor dog samples. In this study, we investigated the sequence variations of BRC3 and 4 in 236 dogs of five breeds. Allele frequencies of 1425P and 1435R were 0.063 and 0.314, respectively, and there was no other polymorphism in the sequenced region. A mammalian two-hybrid assay using BRC3-4 sequences demonstrated that 1425P allele reduced the binding strength with RAD51 but 1435R had no effect. These results may provide an insight into the functions of not only individual but also multiple BRC repeats of BRCA2 in dogs.
In humans, the predisposition to heritable breast and ovarian cancers is associated with mutations in the breast cancer susceptibility gene BRCA2 (7) . The BRCA2 protein plays an important role in the homologous recombination repair (HR) of doublestranded DNA breaks (DSBs) (7) and promotes the assembly of RAD51 recombinase onto single-stranded DNA (6) . To initiate DSB repair by HR, BRCA2 interacts with RAD51 at the highly conserved BRC repeats (BRC) of BRCA2, which consist of 13 conserved amino acid (aa) residues (1) . Among eight BRC repeats (BRC1-8), BRC3 and BRC4 are two best-characterized ones exhibiting strong interaction with RAD51 (10, 18, 21) . Mammary tumors are the most common neoplasia in female dogs, and are highly prevalent in certain dog breeds (17) . It has been reported that BRCA2 mutations are associated with the development of mammary tumors in dogs (4, 12) . We cloned and sequenced canine BRCA2 and found polymorphisms in the putative functional regions containing BRC repeats and nuclear localization signals (8, 19) . In particular, two polymorphisms in BRC3 (4273A> C: T1425P and 4304A>G: K1435R located in the open reading frame of NCBI accession number NM_001006653.4) influenced the interaction with RAD51 (21) . In contrast, mutations or polymor-as high-risk breeds for the development of mammary tumors (17) . On the other hand, Labrador Retriever was recognized as a low-risk breed (17) , and Japanese breed Shiba has not been well described in the literature for mammary tumor predisposition. We aimed to find differences of allele frequencies in polymorphisms of BRC3 between high-and lowrisk breeds in view of mammary tumor susceptibility. All animal experiments were approved by the Experimental Animal Ethics Committee of Nippon Veterinary and Life Science University. The blood samples were originally collected at the Veterinary phisms have not been reported for canine BRC4, although we and others reported that mutations of BRC4 found in human breast cancer patients abolished the interaction with RAD51 (11, 14, 18) . To extend our knowledge of the physiological functions of BRCA2 BRC repeats, and to utilize dogs as a model of human breast cancer, we investigated polymorphic alleles of BRC3 and 4 in multiple dog breeds. We analyzed 236 randomly selected dogs in five breeds (Miniature Dachshund, Labrador Retriever, Shiba, Toy Poodle and Chihuahua). Miniature Dachshund, Toy Poodle and Chihuahua were considered clones, which mimic 6 genotypes identified in this study (Fig. 2) , were transfected into 293T cells. The BRC3-4 combination containing the 1425P allele in BRC3 clearly reduced binding strength that was represented by luciferase activities (Fig. 2) . A recent
Medical Teaching Hospital at NVLU with the written consent of each owner. The collection of samples was performed by licensed veterinarians only. PCR amplification and sequencing of BRC3-4 were performed as previously described (16) using genomic DNA samples and primers shown in Fig. 1 .
To explore the influence of canine BRC3 polymorphisms on the RAD51 interaction, we performed the mammalian two-hybrid assay (MTH). Each type of BRC3-4 fragment and the open reading frame of RAD51 (NM_001003043) were cloned into vectors for MTH. The method of MTH was described in our previous study (9) .
In the sequences of BRC3-4 from 236 dogs, we could not find polymorphisms except for the previously identified T1425P and K1435R. Although 4374A>G: Ser1458Ser silent variation was reported in this region for tumor samples (5), we were unable to find it in the present study. Allele frequencies of 1425P and 1435R were 0.063 and 0.314, respectively, which were calculated from all dogs presented in Table 1 . Interestingly, there were no 1425P alleles in the Labrador Retriever in 51 samples, and only two 1425P homozygotes were identified in the total of 236 (Table 1) . Since Labrador Retriever is recognized as a low-risk breed for mammary tumor susceptibility, the 1425P allele may be associated with predisposition to mammary tumors. To examine this assumption, we need to explore 1425P further in a large group of patients and appropriate controls. In contrast, 1435R was a common polymorphism identified in all five breeds, and was predominant (54/100) in Chihuahua. In addition, the 1425P-1435R allele was not identified in this study (Table 2) , as confirmed by cloning of BRC3 in 13 dogs that had the TP-KR allele. This result suggests that the 1425P and 1435R alleles are derived from different ancestries. The results were derived from three independent experiments and the bar graphs show the luciferase activities in the left column as 100%. A statistically significant difference was observed between 1425TT-1435KK and other types of BRC3-4 (*: P < 0.01). The data of the Western blot analyses show the expression of DBD fused to BRC3-4, AD fused to RAD51 and β-actin after their co-transfection in a parallel experiment. Total  T-K  63  55  35  73  70  296  T-R  13  40  54  29  12  148  P-K  6  5  11  0  6  28  P-R  0  0  0  0  0  0  Total  82  100  100  102  88  472   a Number of haplotypes in each breed b T1425P and K1435R polymorphisms study suggests that BRCA2 forms dimers, in which each BRCA2 interacts with four RAD51 via respective BRC repeats, and acts as a molecular chaperone for RAD51-DNA filament assembly (13) . Because BRC1-4 exhibit higher affinity for RAD51 than do BRC5-8 (2, 3), BRC1-4 may play essential roles in BRCA2 dimers. In a Trypanosoma study, BRC repeat number-dependent RAD51 subnuclear dynamics was recently disclosed (15) . Thus, the T1425P polymorphism in BRC3 that reduces the binding strength for RAD51 may affect the full-length BRC functions. Although K1435R substitution in a single BRC3 led to about a two fold increase in the binding strength with RAD51 (21), it displayed no significant changes in the BRC3-4 function in MTH (Fig. 2) . In summary, we analyzed the polymorphisms of canine BRC3 and 4 in 236 dogs of five breeds, and measured the binding strength of six types of combination of BRC3 polymorphisms with RAD51 using MTH. BRC3-4 containing the 1425P allele showed significant reduction of binding strength with RAD51, but the 1435R allele did not.
